Understanding Stress Urinary Incontinence: Causes, Risk Factors, and Treatment Options

Stress Urinary Incontinence (SUI) is the involuntary leakage of urine during activities that increase intra-abdominal pressure (cough, sneeze, laugh, exercise, lifting). It affects ~30–50% of women across lifespan; prevalence ↑ with age.

Pathophysiology

  • Urethral hypermobility: Weakened pelvic floor/endopelvic fascia → urethra descends with stress → loss of urethral closure pressure
  • Intrinsic sphincter deficiency (ISD): Urethral sphincter incompetence independent of position; severe leakage with minimal stress
  • Most have mixed features

Risk Factors

  • Pregnancy/vaginal delivery: Nerve (pudendal), muscle, fascia trauma; parity dose-response
  • Aging/menopause: Estrogen loss → urethral mucosal atrophy, collagen changes
  • Obesity (BMI ≥30): ↑ intra-abdominal pressure; weight loss ↓ SUI
  • Chronic straining: Constipation, chronic cough (COPD, asthma), heavy lifting
  • Genetics: Collagen variants, family history
  • Prior pelvic surgery: Hysterectomy, anti-incontinence surgery
  • Neurologic: Stroke, MS, Parkinson's (less common for pure SUI)

Symptoms

  • Leakage with cough, sneeze, laugh, jump, run, lift
  • Usually small volumes; no urgency (vs. urge incontinence/OAB)
  • No nocturnal enuresis typically

Diagnosis

  • History + physical (cough stress test, Q-tip test, POP-Q)
  • Urinalysis (rule out UTI)
  • Urodynamics if complex, post-surgical, or ISD suspected

Treatment Ladder

  1. Conservative:
    • Pelvic floor muscle training (PFMT/Kegels) — 3 months supervised → 50–70% cure/improvement
    • Weight loss (if BMI ≥25)
    • Fluid management, caffeine/alcohol reduction
    • Constipation management
    • Vaginal pessary (support)
  2. Pharmacologic (limited): Duloxetine (SNRI) — modest effect; topical estrogen (atrophic urethritis)
  3. Minimally invasive: Urethral bulking agents (Macroplastique, Bulkamid) — ISD
  4. Surgical (gold standard for hypermobility):
    • Midurethral sling (retropubic TVT / transobturator TOT): 85–95% cure at 1 yr
    • Burch colposuspension (open/laparoscopic)
    • Autologous fascial sling (durable, no mesh)

Key Message

SUI is common, treatable, and not an inevitable part of aging. Start with PFMT + lifestyle; escalate based on severity, anatomy, and patient goals. Urogynecologist/urologist evaluation guides optimal pathway.

Urinary Disorders - Related Articles